FTC sues important pharmacy gain managers over insulin rates The agency introduced action versus Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of existence-saving insulin prescription drugs. The deal must be concluded by Sept. 30 or prospective buyers can terminate https://judahcyxus.dsiblogger.com/63509396/everything-about-healthcare-news